For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230519:nRSS9459Za&default-theme=true
RNS Number : 9459Z BioVentix PLC 19 May 2023
Bioventix plc
("Bioventix" or the "Company")
Director/PDMR Shareholdings and Issue of Equity
Bioventix plc (BVXP), a UK company specialising in the development and
commercial supply of high-affinity monoclonal antibodies for applications in
clinical diagnostics, was notified on 18 May 2023 of the following
transactions in its ordinary shares of 5 pence each ("Ordinary Shares"):
Director Role Options over Ordinary Shares exercised Ordinary Shares sold Average sale price per Ordinary Share Ordinary Shares subsequently held Percentage of issued share capital subsequently held
Ian Nicholson Non-Executive Chairman 1,638 1,638 3,651.53 13,000 0.2%
The options over Ordinary Shares ("Options") were exercised at a price of 1350
pence per Ordinary Share pursuant to the Company's 2013 EMI Share Option
Scheme, details of which can be found at www.bioventix.com
(http://www.bioventix.com) . In addition, a current employee exercised 2,333
Options.
Issue of Equity
The Company has applied for 3,971 new Ordinary Shares to be admitted to
trading on AIM ("Admission"). It is expected that Admission will occur and
that dealings will commence in the new Ordinary Shares on 25 May 2023. The new
Ordinary Shares will rank pari passu with the existing Ordinary Shares.
The total number of Ordinary Shares in issue following Admission will be
5,219,656 and the Company holds no shares in treasury. Therefore, the total
number of Ordinary Shares with voting rights in the Company will be 5,219,656.
The above figure of 5,219,656 may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, Bioventix under
the FCA's Disclosure Guidance and Transparency Rules.
For further information please contact:
Bioventix plc Tel: 01252 728 001
Peter Harrison Chief Executive Officer
Bruce Hiscock Chief Financial Officer
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Simon Hicks Corporate Finance
Alice Lane ECM
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities ("PDMR") /
person closely associated ("PCA")
a) Name Ian Nicholson
2. Reason for the Notification
a) Position/status Chairman
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Bioventix plc
b) LEI 213800225MHX7LZQY108
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary Shares of 5 pence each
Identification code GB00B4QVDF07
b) Nature of the transaction Exercise of Options over Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
1,350p 1,638
d) Aggregated information: See 4(c)
· Aggregated volume
· Price
e) Date of the transaction 18 May 2023
f) Place of the transaction Off market transaction
d)
Aggregated information:
· Aggregated volume
· Price
See 4(c)
e)
Date of the transaction
18 May 2023
f)
Place of the transaction
Off market transaction
1 Details of the person discharging managerial responsibilities ("PDMR") /
person closely associated ("PCA")
a) Name Ian Nicholson
2. Reason for the Notification
a) Position/status Chairman
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Bioventix plc
b) LEI 213800225MHX7LZQY108
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary Shares of 5 pence each
Identification code GB00B4QVDF07
b) Nature of the transaction Sale of Ordinary Shares
c) Price(s) and volume(s) Price(s) Volume(s)
3,651.53p 1,638
d) Aggregated information: See 4(c)
· Aggregated volume
· Price
e) Date of the transaction 18 May 2023
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
d)
Aggregated information:
· Aggregated volume
· Price
See 4(c)
e)
Date of the transaction
18 May 2023
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUWRNROSUVAAR